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The increasing of left atrial ANP concentration was promoted by Ang-(1-7). A-779,
API-2, wortmannin, or L-NAME treatment blocked the effects of Ang-(1-7) on
electrophysiological parameters and ANP secretion.
Conclusions: Ang-(1-7) prevented the acute electrical remodeling in rapid atrial
pacing canine model via Ang-(1-7) /Mas/PI3K/Akt/NO signaling pathway. Further-
more, ANP was related to the anti-arrhythmic effects of Ang-(1-7) and may play a
potential role in Ang-(1-7) /Mas/PI3K/Akt/NO signaling pathway.
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Serum chemerin levels and risk of coronary atherosclerosis in early-onset
coronary artery disease of Chinese population
Ying Wang, Dongying Zhang
Department of Cardiology, the First Afﬁliated Hospital of Chongqing Medical
University, Chongqing 400016, China
Objectives: Increasing evidence indicates that adipokines may play an important role
in the pathogenesis of coronary artery disease (CAD). However, it remains uncertain
whether chemerin, a novel adipokine, is associated with coronary atherosclerosis and
could predict for CAD. In the present study, we sought to determine: 1) the rela-
tionship between chemerin and the severity of coronary atherosclerosis, and 2)
whether chemerin is an independent risk factor for CAD in Chinese population.
Methods: 382 early-onset CAD (EOCAD) patients and 305 matched controls un-
dergoing coronary angiography were included into this study. Their serum levels of
chemerin were measured by enzyme-linked immunosorbent assay (ELISA). The
severity of coronary atherosclerosis was evaluated by Gensini score.
Results: Serum chemerin levels of EOCAD patients were signiﬁcantly higher than
that of control subjects (105.0314.62 ng/ml vs. 85.1620.37 ng/ml; P<0.001).
Chemerin had a signiﬁcant positive association with body mass index, LDL-c, tri-
glycerides, and high-sensitivity CRP. Serum chemerin level was positively correlated
with Gensini score (r¼0.384, P<0.001) and negatively associated with adiponectin
(r¼-0.426, P<0.001). In multiple binary logistic regression analysis, chemerin was an
independent risk factor for CAD (OR¼1.218; 95% CI, 1.197-1.340; P<0.05) after
adjusting for conventional cardiovascular risk factors. ROC analysis indicated that
chemerin had greater area than adiponectin with no signiﬁcant difference (P>0.05).
Conclusions: Chemerin is negatively associated with the severity of coronary
atherosclerosis, as well as an independent risk factor for CAD. It may be a promising
target for further elucidating the role of metabolic factors in pathogenesis of CAD.
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Objectives: Myocardial contractility can describe the function of the heart and is an
effective indicator to evaluate whether the heart is health or not. The most effective
way to measure the contractility is using the catheter. There also exists a noninvasive
method which uses pre-ejection period (PEP) to evaluate the contractility. The bal-
listocardiogram (BCG) records the gravity variation caused by the reaction force
during the ejection of blood in heart which highly represents the mechanical activity of
heart. In this paper, we proved the hypothesis that the time interval between the J wave
of BCG and the R wave of electrocardiogram (ECG) which is referred as RJ interval is
correlated to PEP.
Methods: Four healthy male subjects and one male subject with premature ventricular
beats participated in our study. The Doppler echocardiogram (ECHO), ECG and BCG
were recorded synchronously. The PEP is the time interval between the Q wave of
ECG and the beginning of ventricular ﬂow which is a bright line in ECHO. The BCG
measurement system is self-developed by the Institute of Medical Physics and En-
gineering of Tsinghua University, in which the BCG sensor is imbedded on a
wheelchair. It can record the BCG and ECG signals simultaneously. Finally the RJ
intervals were computed easily. RJ intervals were multiplied by the corresponding
squared RR intervals, which were referred as RR interval correction, and its corre-
lation with PEP was also investigated.
Results: In our study, across all the ﬁve subjects, 1974 beats were correlated. The
correlation coefﬁcient r2 of PEP and RJ intervals was 0.79. As for the best linear
ﬁtting, the slope was 1.12, and the intercept was 99.56. The correlation coefﬁcient r2
between PEP and the corrected RJ interval was improved to 0.88. It is summarized the
correlation coefﬁcient r2 of original data and corrected data. In consideration of all the
RJ intervals and RI intervals, the minimum of correlation coefﬁcient was 0.68 and the
maximum was 0.99, except the subject with premature ventricular beats. After
correction, the minimum became 0.88, and the maximum became 0.98. As for the
subject who had premature ventricular beat, the correlation coefﬁcient of RJ interval
and PEP was 0.63, which was much lower than the average level of other normal
subjects. But after RR interval correction, it was improved to 0.8.
Conclusions: The result supports the hypothesis that the PEP is correlated to the RJ.
Consequently, to some extent-at least for healthy people, the corrected RJ intervals
can be suggested as a better indicator for assessment of myocardial contractility.C2 JACC Vol 64/16/Suppl C j OctobHowever, the validity of this correction for those whose cardiac function is abnormal
should be studied in the future. Finally, with our study, BCG, speciﬁcally the cor-
rected RJ interval, can be suggested as an effective method for assessment of
myocardial contractility. Moreover, the BCG measurement system allows family
health care and long-term monitoring of changes in cardiac contractility.
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Prenatal nicotine exposure induces gender-related left ventricular arterial
uncoupling in adult offspring
Wang Zhenhua, Ouyang Qiufang, Huang Ziyang
Second Afﬁliated Hospital of Fujian Medical University
Objectives: Changes in vascular and myocardial structure and function have been
demonstrated in prenatal nicotine exposure offspring, but limited data are available on
how these changes interacted. The present study tested the hypothesis that prenatal
nicotine exposure induces gender-speciﬁc alternations of left ventricular-arterial
coupling indices in adult offspring.
Methods: Female Sprague-Dawley rats were exposed to either nicotine (8 mg/kg/day)
or saline via subcutaneous osmotic mini-pumps throughout the gestation. After 8
months, noninvasive echocardiography and invasive left ventricular cannulation were
performed. Left ventricular arterial coupling was assessed as the ratio of ventricular
end-systolic elastance (Ees) to effective arterial elastance (Ea). Left ventricular
myocardium and aorta were stained with Hematoxylin eosin and myocardial cell
cross-sectional area were calculated.Simultaneously, aortic, internal diameter,and the
ratio of medium thickness to internal diameter were determined. Fibrosis component
of left ventricle mycardium was analysed by Sirius-red staining and further comﬁrmed
by hydroxyproline determination. While the elastic properties of the aortic wall were
analyzed by van Giesson staining.
Results: PNE caused signiﬁcant increases in pulse pressure (567 vs 504, P<0.05)
and left ventricular meridional wall stress (78.259.12 vs 69.647.58, P<0.05) in
male offspring with respect to control. Conversely, no identical effect was found in
females. Elevated augmentation index was noted in both gender pups. Addtionally,
Ea/Ees was reduced in PNE males than control males (0.820.04 vs 0.390.09),
owing to a disproportionate increase in Ees vs. Ea whereas in females, Ea/Ees does not
differ signiﬁcantly due to tandem increases in Ea and Ees. In addition, collagen cross-
linking was markedly higher in male offspring, whereas it was unaltered in females
compared to their respective control. Simultaneously, increased degeneration and
fragmentation of elastic network was noted, as was the ratio of medial thickness to
internal diameter in mesenteric artery.
Conclusions: PNE caused combined ventricular-arterial stiffening in both male and
female offspring, with lower Ea/Ees in male while preserved Ea/Ees in female.
Enhanced collagen cross-linking in mycardium, underdeveloped elastic ﬁbers in aorta,
and remodeled resistance vessels were associated to the pathological ventricular
arterial mismatching. These effects present a gender dichotomy with males being more
susceptible than females.
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Objectives: Angiotensin II (Ang II) is an important causative of diabetic cardiomy-
opathy. In the diabetes, hyperglycemia induces the generation of Ang II in the heart.
Mechanistically the pathogenesis of cardiac Ang II in the development of diabetic
cardiomyopathy was considered its induction of nitrosative and oxidative stress via
Ang II interaction with its receptor 1-mediated NADPH oxidase-mediated generation
of superoxide and peroxynitrite. Nuclear factor-related factor 2 (Nrf2) is a master
regulator of cellular detoxiﬁcation responses and redox status. Sulforaphane (SFN) is
anti-oxidative supplement via up-regulating Nrf2-mediated multiple endogenous
antioxidant enzymes. Therefore, the present study examined whether SFN could
protect from Ang II-induced cardiomyopathy and the underlying mechanism.
Methods: FVB mice were given subcutaneous injection of Ang II (0.5 mg/kg) for 2
months with or without SFN treatment (0.5 mg/kg) for 3 months and then kept until 6
months. At 3 and 6 months, blood pressure and cardiac function were assessed.
Cardiac ﬁbrosis, inﬂammation, and oxidative damage were detected by Western
blotting, real-time PCR, and immunohistochemical staining. Furthermore, cardiac-
overexpressing Nrf2 gene (Nrf2-TG) and wild-type (WT) mice were treated with Ang
II (0.5 mg/kg) for 2 months to conﬁrm the critical roles of cardiac Nrf2 on prevention
of Ang II-induced cardiomyopathy. In vitro, H9c2 cells were treated with SFN and
Ang II with or without Nrf2 siRNA or Akt inhibitor (LY294002) to dissect the
mechanism of SFN’s protective effect.
Results: SFN signiﬁcantly prevented Ang II-induced high blood pressure at 6 months
and cardiac dysfunction at both 3 and 6 months. Ang II caused remarkable patho-
logical changes, including myocardial hypertrophy and collagen accumulation, along
with increases in cardiac oxidative damage (3-NT and 4-HNE), inﬂammation (TNF-a
and PAI-1), and ﬁbrotic response (TGF-b1 and CTGF). Those damages were almost
completely prevented by 3-month SFN treatment that up-regulated Nrf2 function,
reﬂected by increased Nrf2 phosphorylation and downstream antioxidants. To deﬁne
the direct role of SFN-activated Nrf2 in preventing Ang II-induced cardiomyopathy, in
vitro H9c2 cells were treated with Ang II in the absence or presence of Nrf2 siRNA toer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
silence Nrf2 expression. SFN signiﬁcantly up-regulated Nrf2 and also prevented Ang
II-induced CTGF and PAI-1expression, which were completely abolished by Nrf2
silence. Furthermore, Nrf2-TG mice were highly resistant to Ang II-induced cardiac
pathogenic changes and cardiac dysfunction. To dissect the mechanism for SFN acti-
vation of Nrf2, H9c2 cells were given SFN (10 mM) simultaneously with and without
Akt inhibitor (LY294002, 10 mM). SFN’s activation of Nrf2 was partially inhibited by
Akt inhibition that also induced GSK-3b activation and Fyn nuclear accumulation.
Conclusions: Ang II-induced cardiomyopathy can be prevented by SFN via Akt/
GSK-3b/Fyn-mediated activation of Nrf2 antioxidant pathway.
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Post-ischemic myocardial insulin resistance induced by TNF-a overproduction
precipitates the development of heart failure after myocardial infarction
Fu Feng, Jia Li, Jie Xu, Yuan Zhang, Chao Gao, Jun Li, Haifeng Zhang, Feng Gao
Department of physiology, Fourth Military Medical University
Objectives: Clinical evidence has demonstrated a decreased myocardial insulin
response in heart failure (HF) patients. The objective of this study is to investigate the
role of myocardial insulin resistance in the development of ischemic HF and its un-
derlying mechanisms.
Methods: Adult male Sprague Dawley rats were subjected to a permanent occlusion
of the left anterior descending coronary artery. Cardiac function and remodeling were
evaluated by echocardiographic. Insulin stimulated myocardial ﬂuorodeoxyglucose
(FDG) uptake were measured by micro-PET/CT.
Results: Rats subjected to myocardial infarction (MI) resulted in a progressive left
ventricular (LV) remodeling and dysfunction. Echocardiographic assessment showed
preserved LV end-systolic dimension (LVESD 0.4530.027 cm) and ejection fraction
(EF 57.032.35%) at 1 week after MI, and evident LV dilation (LVESD
0.6210.026 cm) and dysfunction (EF 40.123.09%) at 4 weeks. Myocardial insulin
sensitivity decreased signiﬁcantly at 1 week after MI as evidenced by reduced insulin-
stimulated myocardial ﬂuorodeoxyglucose uptake (Standardized Uptake Value:
2.710.42 vs. 5.130.51 of sham+insulin, n¼6, P<0.01) and GLUT-4 translocation
and altered insulin signaling. Meanwhile, MI increased myocardial TNF-a production.
Treatment with Etanercept (a TNF-a inhibitor) during the ﬁrst week following MI
improved myocardial insulin sensitivity, while adenovirus-mediated cardiac over-
expression of TNF-a resulted in myocardial insulin resistance in non-MI hearts.
In addition, TNF-a overexpressed rat hearts exhibited LV dysfunction
(EF 41.324.21%) and LV dilation (LVESD 0.6270.036 cm) as early as 1 wk after
MI. More importantly, tamoxifen-induced cardiomyocyte-speciﬁc insulin receptor
knockout mice developed aggravated post-ischemic LV remodeling and dysfunction
compared with littermate controls (EF 31.542.41 vs. 45.322.65 %, LVESV
31.542.41 vs. 45.212.65 ml, both P<0.05). Insulin treatment during the ﬁrst week
following MI not only suppressed myocardial TNF-a production and increased
myocardial insulin sensitivity, but also alleviated cardiac dysfunction and remodeling
at 4 wk after MI.
Conclusions: Myocardial insulin resistance induced at least partly by TNF-a over-
production following MI contributes to the development of post-ischemic HF, which
indicates an essential role of myocardial insulin signaling in protection against
ischemic HF.
GW25-e4306
Angiotensin-(1-7) stimulates cholesterol efﬂux from angiotensin II-treated
cholesterol-loaded THP-1 macrophages through suppression of p38 and
JNK signaling
Yang Huiyu, Yun-fei Bian, Chuan-shi Xiao, Rui Bai, Bin Liang, Na-na Zhang,
Fen Gao, Yang Zhiming
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Objectives: Angiotensin II (Ang II) and angiotensin-(1-7) (Ang-(1-7) ) are key
effector peptides of the renin-angiotensin system. The aim of this study is to inves-
tigate the effects of Ang-(1-7) on Ang II-stimulated cholesterol efﬂux and associated
molecular mechanisms.
Methods: Differentiated THP-1 macrophages were treated with Ang II (1 mM) and/or
Ang-(1-7) (10 and 100 nM) for 24 h and cholesterol efﬂux and gene expression were
assessed. Pharmacology inhibition of peroxisome proliferator-activated receptor
gamma (PPARg) and mitogen-activated protein kinases (MAPKs) were done to
identify the signaling pathways involved.
Results: Our results showed that Ang II signiﬁcantly inhibited cholesterol efﬂux from
cholesterol-loaded THP-1 macrophages. Ang-(1-7) led to a dose-dependent restoration
of cholesterol efﬂux in Ang II-treated cells. The co-treatment with Ang-(1-7) and Ang
II signiﬁcantly increased the ABCA1 and ABCG1 expression relative to treatment
with Ang II alone, which was coupled with increased expression of PPARg and liver
X receptor alpha (LXRa). Pharmacological inhibition of PPARg signiﬁcantly
(P<0.05) abolished Ang-(1-7) -mediated induction of ABCA1 and ABCG1 mRNA
expression. Ang-(1-7) treatment caused an inactivation of JNK and p38 MAPK
signaling in Ang II-treated THP-1 macrophages. Moreover, inhibition of JNK or p38
MAPK signaling using speciﬁc pharmacological inhibitors mimicked the induction of
PPARg and LXRa expression by Ang-(1-7).
Conclusions: Taken together, our data demonstrate that Ang-(1-7) promotes choles-
terol efﬂux in Ang II-treated THP-1 macrophages in part through inactivation of p38
and JNK signaling and induction of PPARg and LXRa expression and may thus have
therapeutic beneﬁts in atherosclerosis.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BGW25-e4414
Berberine improves coronary vasodilation and prevents endothelial apoptosis via
activating Akt-eNOS in diabetic rats
Li Jiani, Zhao Zhang, Wen-Juan Xing, Feng-Hao Geng, Ling Dong, Feng Gao
The Fourth Military Medical University
Objectives: The impaired endothelial cells are the major cause of vessel dysfunction
in diabetes. Berberine, an isoquinoline alkaloid, has been demonstrated to lower blood
glucose and regulate lipid metabolism disorders, while the mechanism of protection of
berberine in diabetic cardiovascular disease remains elusive. In present study, we
sought to study the effects of berberine on diabetes coronary artery vessel dysfunction
and the underling mechanisms.
Methods: Diabetic rat were induced by injected streptozotocin and fed with a high-fat
diet for 12 weeks. Rats were randomized to receiving saline or berberine treatments
(200 mg/kg/d, gravage) in the last 4 weeks. HUVECs were cultured in HG/HF
(25 mmol/L glucose DMEM and 500 mmol/L palmitate) to simulate the damage
endothelial dysfunction of diabetes in vitro.
Results: Coronary arteries from berberine treated diabetic rats exhibited an obvious
ACh-induced vasodilatation enhancement. Moreover, berberine treatment improves
the insulin mediated vasodilatation of coronary artery compared with the diabetic rats
(26.6% vs. 3.2%, n¼12, P<0.01). More interestingly, the beneﬁcial effects of
berberine on vasodilatation were blunted by wortmannin, an inhibitor of PI3K/Akt.
According to TUNEL staining, treatment of berberine signiﬁcantly attenuated diabetic
rats coronary artery endothelium apoptosis. In vitro study, berberine treatment reduced
HG/HF-induced HUVECs apoptosis, increased Bcl-2/Bax ratio and decreased cas-
pase-3 expression signiﬁcantly, together with enhanced Akt, GSK3b and eNOS
phosphorylation. While, pretreatment with either wortmannin or AMPK inhibitor
Compound C, the anti-apoptotic effect of berberine were signiﬁcantly blunted.
Conclusions: Berberine enhances vasodilatation and protects against endothelial
apoptosis in diabetes rats coronary artery, which is mainly through the activation of
the Akt-eNOS signaling.
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High levels of circulating endothelial microparticles and increased tissue factor
procoagulant activity of plasma microparticles in patients with acute coronary
syndromes
Zhao Can, Guo Danjie
Peking University People’s Hospital
Objectives: Microparticles (MPs) are submicron vesicles released from activated or
apoptotic cells and involved in message delivering. Elevated numbers of platelet
microparticles (PMPs) and endothelial microparticles (EMPs) have been reported in
patients with acute coronary syndrome (ACS). The purpose of this study was to assess
levels and tissue factor procoagulant activity of circulating MPs in patients with ACS.
Methods: AnnexinVpositive MPs (AMPs), PMPs, CD31 positive EMPs, CD62E
positive EMPs, and monocyte MPs (MMPs) were measured in 36 patients with ACS.
We also enrolled 16 healthy individuals as normal controls. Calibrated automated
thrombogram assay was used to evaluate the MP-mediated thrombin generation
among ACS patients and normal controls. The lag time, time to peak, endogenous
thrombin potential (ETP), peak thrombin generation between two groups were
measured and compared. Furthermore, we investigated the association between var-
iables such as numbers of MPs, lag time, endogenous thrombin potential, high-
sensitivity C-reactive protein (hs-CRP), and peak value of cardiac troponin I (TnI).
Results: CD31 positive EMPs with the concentration of 1118 /mL were main circu-
lating MPs in ACS patients. Through thrombin generation test, both the ETP
(924.2349.9 vs 652.3146.7 nMmin, P¼0.001) and the peak (87.539.6 vs
55.024.4 nM, P¼0.002) increased in ACS patients compared with those of healthy.
For ACS patients, the levels of AMPs were negatively correlated with the peak value
of TnI (rp¼ -0.416, P¼0.028), while the levels of CD31 positive EMPs were nega-
tively correlated with high-density lipoprotein cholesterol (HDL-C) (rp¼ -0.493,
P¼0.009).
Conclusions: CD31 positive EMPs were the main circulating MPs presented in ACS
patients. Compared to healthy, tissue factor procoagulant activity of plasma MPs
increased in patients with ACS.
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Role of perivascular adipose tissue-derived LET-7B in vascular inﬂammation
VIA ADRB3
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Objectives: Vascular injury caused by hypertension is a chronic low-grade inﬂam-
mation process, especially a growing number of studies have shown that inﬂammatory
response in vascular adventitial not only involved in hypertension, but also in
atherosclerosis and vascular restenosis. As the important composition of outer
membrane, perivascular adipose tissue (PVAT) secretes a variety of biological active
substances involved in regulation of vascular pathophysiology function. Our previous
study found that PVAT secretes inﬂammatory factors involved in vascular remodeling
in DOCA-salt hypertensive model. And the expression of inﬂammatory factor is
regulated by many factors at the transcription and post-transcription level. MiRNAsasic and Translational Medicine C3
